What is Procaps Group?
Founded in 2021, Procaps Group has rapidly established itself as a significant player in the pharmaceutical and nutraceutical sectors. The company operates a sophisticated manufacturing network that serves a diverse international clientele, focusing on the synthesis of innovative healthcare products. By integrating advanced manufacturing processes with a deep understanding of global regulatory requirements, Procaps Group provides critical support to the medical supply chain. Its market position is defined by a dual focus on high-quality pharmaceutical production and the development of specialized nutraceutical solutions, ensuring that the company remains at the forefront of therapeutic innovation and patient care.
How much funding has Procaps Group raised?
Procaps Group has raised a total of $130M across 1 funding round:
Private Equity
$130M
Private Equity (2025): $130M with participation from Flying Fish Partners, Santana, and Chemo
Key Investors in Procaps Group
Flying Fish Partners
Flying Fish Partners is a Seattle-based venture firm that provides capital and strategic support to high-potential technology companies, with a specific focus on AI and machine learning applications.
Santana
Santana SA is a Chile-based financial institution operating within the banking sector, providing essential capital and financial services to support regional and international business growth.
Chemo
Chemo is a global leader in the research, development, and manufacturing of active pharmaceutical ingredients and finished dosage forms, serving over 1,115 clients worldwide with a focus on therapeutic innovation.
What's next for Procaps Group?
Looking ahead, the strategic deployment of this capital will likely focus on enhancing R&D capabilities and optimizing global supply chain efficiencies. As the company navigates the complexities of the pharmaceutical industry, the focus will remain on scaling production capacity to meet the rising demand for high-quality hospital supplies and OTC products. By prioritizing technological integration and operational excellence, Procaps Group is poised to strengthen its market share and drive long-term value for its stakeholders. The firm's ability to execute on its growth strategy will be critical as it continues to navigate the evolving global healthcare environment.
See full Procaps Group company page
